P
Pacira BioSciences, Inc.
PCRX · NASDAQ · Healthcare · 905M
Closing price
$36.31
-0.22% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
230.1×
Price / net assetsP/B
2.3×
Enterprise value / EBITDAEV/EBITDA
15.6×
Free cash flow yieldFCF yield
8.4%
Return on equityROE
1.0%
Operating margin
4.6%
Net debt / EBITDAbalance-sheet strength
2.4×
Interest coverage
2.3×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.